The Traderszone Network

Published in TZ Latest News 5 December, 2021 by The TZ Newswire Staff

Junshi Biosciences Announces FDA Expanded Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Individuals under the Age of 12

First and only neutralizing antibody therapy for this age group First and only neutralizing antibody therapy for this age group